Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-01 Sale |
2023-06-01 4:29 pm |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
109,459 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-01 Sale |
2023-06-01 4:27 pm |
TCR2 THERAPEUTICS INC. | TCRR | Olagunju Peter Chief Operating Officer |
24,092 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-01 Sale |
2023-06-01 4:22 pm |
TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO |
404,330 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-06-01 Sale |
2023-06-01 4:21 pm |
TCR2 THERAPEUTICS INC. | TCRR | Justice Angela Chief People Officer |
48,745 | $0 | $0 | 0 (Direct) |
View |
| 2023-05-25 Purchase |
2023-05-30 8:02 pm |
TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
50,000 | $1.72 | $86,000 | 4,394,800 (Indirect) |
View |
| 2023-05-22 Sale |
2023-05-24 4:39 pm |
TCR2 THERAPEUTICS INC. | TCRR | MPM ASSET MANAGEMENT LLC EVNIN LUKE 10% Owner |
70,170 | $1.88 | $131,920 | 3,674,978 (Indirect Direct) |
View |
| 2023-05-22 Sale |
2023-05-24 4:38 pm |
TCR2 THERAPEUTICS INC. | TCRR | GADICKE ANSBERT Director 10% Owner |
70,170 | $1.88 | $131,920 | 7,529,946 (Indirect) |
View |
| 2023-05-11 Purchase |
2023-05-15 5:12 pm |
TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
44,948 | $1.95 | $87,649 | 4,344,800 (Indirect) |
View |
| 2023-05-08 Purchase |
2023-05-10 7:02 pm |
TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
83,988 | $1.95 | $163,777 | 4,299,852 (Indirect) |
View |
| 2023-05-03 Purchase |
2023-05-05 6:52 pm |
TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
289,577 | $1.8922 | $547,944 | 4,215,864 (Indirect) |
View |
| 2022-12-09 Sale |
2022-12-13 8:26 pm |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
13,799 | $1.0959 | $15,123 | 232,717 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 8:24 pm |
TCR2 THERAPEUTICS INC. | TCRR | Olagunju Peter Chief Technical Officer |
4,830 | $1.097 | $5,298 | 53,014 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 8:21 pm |
TCR2 THERAPEUTICS INC. | TCRR | Justice Angela Chief People Officer |
8,620 | $1.096 | $9,448 | 106,110 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 8:19 pm |
TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO |
31,938 | $1.0969 | $35,034 | 575,139 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-01 Other |
2024-02-14 5:25 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
4,394,800 | $0 | 4,394,800 (Indirect) |
View |
| 2023-06-01 Other |
2023-06-05 4:37 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner |
3,370,982 | $0 | 3,370,982 (Direct) |
View |
| 2023-06-01 Other |
2023-06-05 4:36 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | MPM SunStates Fund L.P. MPM Asset Management Investors SunStates Fund LLC MPM SunStates Fund GP LLC MPM SunStates GP Managing Member LLC 10% Owner |
4,158,964 | $0 | 4,158,964 (Indirect) |
View |
| 2023-06-01 Other |
2023-06-05 4:36 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | MPM BioVentures 2014 L.P. Foley Todd EVNIN LUKE MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM ASSET MANAGEMENT LLC 10% Owner |
4,158,964 | $0 | 4,158,964 (Indirect) |
View |
| 2023-06-01 Other |
2023-06-05 4:35 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | GADICKE ANSBERT Director 10% Owner |
7,529,946 | $0 | 7,529,946 (Indirect) |
View |
| 2023-05-22 Exercise |
2023-05-24 4:39 pm |
2016-12-13 2026-12-12 |
TCR2 THERAPEUTICS INC. | TCRR | MPM ASSET MANAGEMENT LLC EVNIN LUKE 10% Owner |
178,269 | $0 | 3,674,978 (Direct) |
View |
| 2023-05-22 Exercise |
2023-05-24 4:39 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | MPM ASSET MANAGEMENT LLC EVNIN LUKE 10% Owner |
178,269 | $0.74 | 3,674,978 (Direct) |
View |
| 2023-05-22 Exercise |
2023-05-24 4:38 pm |
2016-12-13 2026-12-12 |
TCR2 THERAPEUTICS INC. | TCRR | GADICKE ANSBERT Director 10% Owner |
178,269 | $0 | 7,529,946 (Indirect) |
View |
| 2023-05-22 Exercise |
2023-05-24 4:38 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | GADICKE ANSBERT Director 10% Owner |
178,269 | $0.74 | 7,529,946 (Indirect) |
View |
Ownership |
2023-05-05 6:49 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner |
0 | $0 | 3,926,287 (Indirect) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:44 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
82,424 | $0 | 191,883 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:32 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO |
277,689 | $0 | 682,019 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:29 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Sullivan Eric Chief Financial Officer |
47,624 | $0 | 47,624 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:25 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Olagunju Peter Chief Technical Officer |
114,478 | $0 | 138,570 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:25 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Justice Angela Chief People Officer |
91,582 | $0 | 140,327 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:24 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Allen Andrew R Director |
16,800 | $0 | 16,800 (Direct) |
View |
| 2021-12-09 Option Award |
2022-12-19 5:19 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Gibson Neil W Director |
16,800 | $0 | 16,800 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:18 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Hegde Priti Director |
16,800 | $0 | 16,800 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:16 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Hoos Axel Director |
16,800 | $0 | 16,800 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:13 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Harrison Rosemary Chief Business & Strategy |
89,752 | $0 | 89,752 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:10 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Tomasello Shawn Director |
16,800 | $0 | 16,800 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 5:06 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Webster Stephen W Director |
16,800 | $0 | 16,800 (Direct) |
View |